Indium In 111 Oxyquinoline

CHEMBL1200452 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
543.4 g/mol
LogP
Phase
4

A radioactive tracer in which indium-111 is bound to oxyquinoline, used to label white blood cells or platelets so they can be tracked by imaging to locate infections, inflammation, or blood clots. It is a diagnostic imaging agent only, not a treatment.

Molekularmasse

543,4000 g/mol

TPSA

108,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[111In+3]

InChI

InChI=1S/3C9H7NO.In/c3*11-8-5-1-3-7-4-2-6-10-9(7)8;/h3*1-6,11H;/q;;;+3/p-3/i;;;1-4

Molecular Formula

C27H18InN3O3

HBD / HBA

- / 6

Rotierbare Bindungen

0

Schwere Atome

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A radioactive tracer in which indium-111 is bound to oxyquinoline, used to label white blood cells or platelets so they can be tracked by imaging to locate infections, inflammation, or blood clots. It is a diagnostic imaging agent only, not a treatment.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Indium In 111 Oxyquinoline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200452. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 119117. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.